61919-0218 Ondansetron - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

61919-0218

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 8.0

Unit: mg/1

Packages:

Code: 61919-0218-10

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (61919-218-10)

Effective Date: Jan. 1, 2014

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use